TECHNOLOGY COMMERCIALIZATION
SEARCH
Available Technologies:
Life Science
|
Physical Science
|
Research Tools
|
Software
Search Results - qunfang+lee
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
GlyB4 Fusion with Neuregulin Heparin-Targeting Domain to Block Neuregulin Signaling
We have harnessed this natural targeting ability of NRG by fusing the HBD of NRG to soluble HER4. This fusion protein retains high affinity heparin binding to heparin and to cells that express heparan sulfates resulting in a more potent NRG antagonist. In vivo, it is targeted to peripheral nerve segments where it blocks the activity of NRG as a Schwann...
Published: 2/6/2014
|
Inventor(s):
Jeffrey Loeb
,
Qunfang Lee
Keywords(s):
Anti-cancer
,
Biotechnology
,
Cancer risk
,
Cancer Therapies
,
Drug Delivery
,
Drug Target
,
Epilepsy
Category(s):
Life Science
,
Drug Delivery
,
Other